Posted in | News

BASF to Increase Dimethylaminopropylamine Production to 35000 TPY

BASF will raise its annual capacity to produce dimethylaminopropylamine (DMAPA) from 21,000 to 35,000 metric tons. The company thus responds to the worldwide increase in demand for this intermediate, which is used mainly to make particularly skin-friendly personal care products. As the world’s largest manufacturer, BASF produces DMAPA at two plants: one in Ludwigshafen, Germany; the other in Geismar, Louisiana/USA. The company will boost its capacity by taking a variety of measures to optimize the production at its Ludwigshafen plant.

“As a leading global supplier of amines we stepped up our DMAPA capacity before, in 2003, and we will continue to support our customers’ growth in Europe, the NAFTA region and Asia,” says Dr. Walter Gramlich, head of BASF’s Intermediates division. “Along with reliable supply, our customers appreciate our high demands on quality and our innovativeness.”

BASF is unique in that it manufactures the two raw materials dimethylamine and acrylonitrile that form the ingredient. The company therefore provides high-level delivery reliability and consistently high product quality. Most of the DMAPA is processed to special surfactants, which are raw materials for personal care products. They give shampoos, shower gels, liquid soaps and washing-up liquids their mildness. These products consequently do not sting or hurt the eyes, make a nice, fine-bubble foam, and are readily compatible with other shampoo additives. DMAPA offers benefits even after its use: it is highly biodegradable.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.